InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank29
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-8.16M
Near historical average
Percentile
P29
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-8.60M
Historical baseline
PeriodValueYoY Change
2025$-8.16M-6.3%
2024$-7.68M+3.4%
2023$-7.95M+57.3%
2022$-18.60M-47.0%
2021$-12.65M-41.5%
2020$-8.94M+10.7%
2019$-10.01M-49.2%
2018$-6.71M-95.0%
2017$-3.44M-87.2%
2016$-1.84M-